PhD LIVE Study Fair

Oxford | Edinburgh | Sheffield

Coventry University Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Reading Featured PhD Programmes

Cancer / Oncology (metabolism) PhD Projects, Programs & Scholarships

We have 34 Cancer / Oncology (metabolism) PhD Projects, Programs & Scholarships

  • "metabolism" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 11 to 20 of 34
  Evaluation of ex vivo screening methodology
  Dr S Danson, Prof T Helleday
Applications accepted all year round

Funding Type

PhD Type

Cancer affects over 14M individuals worldwide each year and in the UK only 50% of patients have a 10 year survival following cancer diagnosis.
  Non-invasive Mapping of Oxygen Extraction Fraction in Patients with Breast Cancer: Development of Novel Multi-Parametric Relaxometry Magnetic Resonance Imaging (MRI) Methods
  Dr J He, Dr Y Masannat, Prof D Lurie
Applications accepted all year round

Funding Type

PhD Type

This project aims to translate, optimise and extend quantitative oxygen extraction fraction mapping based on oxygen enriched air inspiration and magnetic resonance (MR) relaxometric imaging for human application.
  Fueling chemotherapy resistance in triple-negative breast cancer
  Dr K Brown
Applications accepted all year round

Funding Type

PhD Type

Triple-negative breast cancer (TNBC) is a molecularly heterogeneous group of diseases defined by the lack of estrogen receptor (ER), progesterone receptor (PR) and absence of human epidermal growth factor receptor-2 (HER2) amplification.
  Metabolic Reprogramming in Liver Cancer: delineating the role of reactive oxygen species (ROS) in tumour development
  Prof T. Tiganis
Applications accepted all year round

Funding Type

PhD Type

The Tiganis Laboratory is seeking a highly enthusiastic student to conduct research in cancer metabolism and obesity-associated liver cancer.
  The role of metabolic adaptive changes in therapy resistance in Acute myeloid leukaemia (AML)
  Research Group: Barts Cancer Institute
  Dr P Gallipoli
Application Deadline: 14 October 2019

Funding Type

PhD Type

A graduate with an interest in Cancer Biology, with or is expecting at least an upper second class honours degree in biological / biochemistry subject is required for this project involving the study of metabolic adaptive changes in therapy resistance in AML.
  Design, synthesis and evaluation of protease-activated anti-cancer prodrugs
  Research Group: Institute of Cancer Therapeutics
  Dr R Falconer, Prof P Loadman
Applications accepted all year round

Funding Type

PhD Type

Matrix metalloproteinases (MMPs) are a family of endoproteases that are overexpressed in tumours and play crucial roles in many tumourigenic processes, not least tumour invasion and angiogenesis.
  Novel bone-targeted therapy for multiple myeloma
  Dr M Lawson, Dr A Chantry
Applications accepted all year round

Funding Type

PhD Type

Myeloma remains an incurable cancer despite improvements in survival outcomes over the last few years, due to the development of better therapies.
  An intelligent scheme to identify novel drug targets through analysing the DNA repairome in drug resistant cancer?
  Research Group: Biomedical Research Group
  Prof C Parris
Applications accepted all year round

Funding Type

PhD Type

Research Group. Biomedical Research Group. https://www.anglia.ac.uk/science-and-engineering/research/institutes-and-groups/biomedical.
  Stimulating the sirtuin family in the treatment of cancer.
  Dr P Ragazzon
Applications accepted all year round

Funding Type

PhD Type

Every year, thousands of people face cancer diagnosis. Survival rates are high, but many face devastating disabilities and long-term side effects resulting from currently treatments.
  Unravelling the oncogenic activities of serum- and glucocorticoid-regulated kinase 1 (SGK1)
  Dr K Brown
Applications accepted all year round

Funding Type

PhD Type

The phosphoinositide 3-kinase (PI3K) pathway is a master regulator of numerous cellular phenotypes associated with cancer including cell survival, proliferation, growth, altered metabolism and malignant transformation.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.